BACKGROUND: The feasibility of carotid artery intima-media thickness (C-IMT), an established cardiovascular disease marker, as a cardiac risk marker in mucopolysaccharidosis (MPS) patients was explored. OBJECTIVES: To determine if C-IMT is abnormal in MPS versus unaffected controls, and if C-IMT correlates with coronary artery diameter in MPS. MATERIAL AND METHODS: Measurements of C-IMT via neck ultrasound and echocardiographic parameters, including coronary artery diameters, were obtained from MPS and control patients, and compared. RESULTS: Sixteen MPS subjects (6 MPS I, 6 MPS II, 2 MPS III, 1 MPS VI, 1 MPS VII) and sixteen age, ethnicity, and gender-matched controls were enrolled. Median MPS and control subject ages were 8.3±4.5 and 8.6±4.3 years, respectively (p=0.73). Mean MPS and control C-IMTs were 0.54±0.070 and 0.48±0.034 mm (p=0.0029). No differences in left main, left anterior descending, or right coronary artery diameters were seen between MPS and controls. A significant proportion of MPS subjects had mitral insufficiency (14/16; p=0.0002), aortic insufficiency (10/16; p=0.0021), and left ventricular dilatation (7/16, p=0.037) versus controls. C-IMT did not correlate significantly with age, height, weight, coronary measurements, or duration of treatment. CONCLUSION: C-IMT in MPS patients is increased compared to matched controls, likely reflective of arterial intima-medial glycosaminoglycan accumulation. MPS subjects demonstrated a high percentage of left-sided valvular insufficiency and ventricular dilatation. Additional studies should be performed in MPS patients to determine if C-IMT correlates with arterial elasticity, biomarkers of vascular dysfunction, and higher risk of cardiovascular events.
BACKGROUND: The feasibility of carotid artery intima-media thickness (C-IMT), an established cardiovascular disease marker, as a cardiac risk marker in mucopolysaccharidosis (MPS) patients was explored. OBJECTIVES: To determine if C-IMT is abnormal in MPS versus unaffected controls, and if C-IMT correlates with coronary artery diameter in MPS. MATERIAL AND METHODS: Measurements of C-IMT via neck ultrasound and echocardiographic parameters, including coronary artery diameters, were obtained from MPS and control patients, and compared. RESULTS: Sixteen MPS subjects (6 MPS I, 6 MPS II, 2 MPS III, 1 MPS VI, 1 MPS VII) and sixteen age, ethnicity, and gender-matched controls were enrolled. Median MPS and control subject ages were 8.3±4.5 and 8.6±4.3 years, respectively (p=0.73). Mean MPS and control C-IMTs were 0.54±0.070 and 0.48±0.034 mm (p=0.0029). No differences in left main, left anterior descending, or right coronary artery diameters were seen between MPS and controls. A significant proportion of MPS subjects had mitral insufficiency (14/16; p=0.0002), aortic insufficiency (10/16; p=0.0021), and left ventricular dilatation (7/16, p=0.037) versus controls. C-IMT did not correlate significantly with age, height, weight, coronary measurements, or duration of treatment. CONCLUSION:C-IMT in MPSpatients is increased compared to matched controls, likely reflective of arterial intima-medial glycosaminoglycan accumulation. MPS subjects demonstrated a high percentage of left-sided valvular insufficiency and ventricular dilatation. Additional studies should be performed in MPSpatients to determine if C-IMT correlates with arterial elasticity, biomarkers of vascular dysfunction, and higher risk of cardiovascular events.
Authors: Nathan J Palpant; Fikru B Bedada; Brandon Peacock; Bruce R Blazar; Joseph M Metzger; Jakub Tolar Journal: Am J Physiol Heart Circ Physiol Date: 2010-11-12 Impact factor: 4.733
Authors: Leonie van den Broek; Ad P C M Backx; Hans Coolen; Frits A Wijburg; Ron Wevers; Eva Morava; Chris Neeleman Journal: Pediatrics Date: 2011-04-04 Impact factor: 7.124
Authors: S A Jones; Z Almássy; M Beck; K Burt; J T Clarke; R Giugliani; C Hendriksz; T Kroepfl; L Lavery; S-P Lin; G Malm; U Ramaswami; R Tincheva; J E Wraith Journal: J Inherit Metab Dis Date: 2009-07-14 Impact factor: 4.982
Authors: Anne M Traas; Ping Wang; Xiucui Ma; Mindy Tittiger; Laura Schaller; Patricia O'donnell; Meg M Sleeper; Charles Vite; Ramin Herati; Gustavo D Aguirre; Mark Haskins; Katherine P Ponder Journal: Mol Ther Date: 2007-05-22 Impact factor: 11.454
Authors: Elizabeth A Braunlin; Paul R Harmatz; Maurizio Scarpa; Beatriz Furlanetto; Christoph Kampmann; James P Loehr; Katherine P Ponder; William C Roberts; Howard M Rosenfeld; Roberto Giugliani Journal: J Inherit Metab Dis Date: 2011-07-09 Impact factor: 4.982
Authors: Carolyn M Wilhelm; Kristen V Truxal; Kim L McBride; John P Kovalchin; Kevin M Flanigan Journal: Mol Genet Metab Date: 2018-04-27 Impact factor: 4.797
Authors: Raymond Y Wang; Elizabeth A Braunlin; Kyle D Rudser; Donald R Dengel; Andrea M Metzig; Kelly K Covault; Lynda E Polgreen; Elsa Shapiro; Julia Steinberger; Aaron S Kelly Journal: Mol Genet Metab Date: 2013-11-12 Impact factor: 4.797
Authors: Omar Khalid; Moin U Vera; Philip L Gordts; N Matthew Ellinwood; Philip H Schwartz; Patricia I Dickson; Jeffrey D Esko; Raymond Y Wang Journal: PLoS One Date: 2016-03-17 Impact factor: 3.240
Authors: Raymond Y Wang; Kyle D Rudser; Donald R Dengel; Elizabeth A Braunlin; Julia Steinberger; David R Jacobs; Alan R Sinaiko; Aaron S Kelly Journal: Int J Mol Sci Date: 2017-03-15 Impact factor: 5.923
Authors: Raymond Y Wang; Kyle D Rudser; Donald R Dengel; Nicholas Evanoff; Julia Steinberger; Nina Movsesyan; Robert Garrett; Katherine Christensen; Deborah Boylan; Stephen R Braddock; Marwan Shinawi; Qi Gan; Adriana M Montaño Journal: Orphanet J Rare Dis Date: 2020-03-17 Impact factor: 4.123